Pituitary

Papers
(The TQCC of Pituitary is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
A Pituitary Society update to acromegaly management guidelines150
COVID-19 and the pituitary65
Postoperative diabetes insipidus: how to define and grade this complication?50
Pituitary apoplexy associated with acute COVID-19 infection and pregnancy48
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective46
Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis43
Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review41
The 5-factor modified frailty index predicts health burden following surgery for pituitary adenomas36
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review35
Descriptive epidemiology of craniopharyngiomas in the United States34
Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas26
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly26
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement24
Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review24
Feasibility of machine learning based predictive modelling of postoperative hyponatremia after pituitary surgery24
Trends in endoscopic and microscopic transsphenoidal surgery: a survey of the international society of pituitary surgeons between 2010 and 202023
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection23
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score21
Mice with gene alterations in the GH and IGF family20
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study20
Pre-operative serum inflammation-based scores in patients with pituitary adenomas19
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome19
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma17
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome17
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States17
Ectopic pituitary adenomas: clinical features, diagnostic challenges and management15
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI15
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas15
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice15
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study15
Do nothing but observe microprolactinomas: when and how to replace sex hormones?15
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis15
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study15
Opioids and pituitary function: expert opinion15
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis14
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease14
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation14
Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study14
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency14
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study14
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas13
Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age13
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile13
Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience13
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly12
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system12
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications12
Metabolic syndrome and its components in adult hypopituitary patients12
Normative data for pituitary size and volume in the general population between 50 and 66 years12
Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification12
The NETting of pituitary adenoma: a gland illusion12
The sellar barrier on preoperative imaging predicts intraoperative cerebrospinal fluid leak: a prospective multicenter cohort study12
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression11
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma11
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples11
ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome11
Cushing’s disease: adrenal steroidogenesis inhibitors11
Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery11
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients11
Typing of inflammatory lesions of the pituitary10
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)10
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results10
Glucocorticoid receptor blockers10
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis10
The importance of specialized sleep investigations in children with a suprasellar tumor10
Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis10
Modern imaging in Cushing’s disease10
Prolactin immunoassay: does the high-dose hook effect still exist?10
Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis10
Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST)10
Quality of life impairment after a diagnosis of Cushing’s syndrome10
HOMA-IR in acromegaly: a systematic review and meta-analysis10
AIP variant causing familial prolactinoma10
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients9
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis9
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience9
Targeted therapies in the medical management of craniopharyngioma9
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas9
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers9
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)9
Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study9
Cardiovascular health and mortality in Cushing’s disease9
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery8
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity8
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis8
Professor Rathke’s gift to neurosurgery: the cyst, its diagnosis, surgical management, and outcomes8
The epidemiology and management patterns of pediatric pituitary tumors in the United States8
High accuracy of bilateral and simultaneous petrosal sinus sampling with desmopressin for the differential diagnosis of pediatric ACTH-dependent Cushing’s syndrome8
Copeptin response to hypoglycemic stress is linked to prolactin activation in children8
Genetic spectrum and predictors of mutations in four known genes in Asian Indian patients with growth hormone deficiency and orthotopic posterior pituitary: an emphasis on regional genetic diversity8
Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case–control study8
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively8
Management of prolactinomas in children and adolescents; which factors define the response to treatment?8
0.02532696723938